Methods for determining drug responsiveness
AssigneeUniversity of Pennsylvania
InventorsAlexander Steven Whitehead, Sharon S. Challberg, James G. Lazar
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Pennsylvania
InventorsAlexander Steven Whitehead, Sharon S. Challberg, James G. Lazar
Estimating the term…
The invention provides a diagnostics assay for measuring the responsiveness to a drug by comparing the mRNA levels of a gene that responds to the drug, such as a steroid, to the mRNA levels of a gene that does not respond to the drug. Methods according to the invention are useful for predicting the ability of a patient (or a tissue, body fluid or cell sample in vitro) to respond to a drug or steroid at any stage of their treatment (i.e., before, during or after), and to monitor the patient (or a tissue, body fluid or cell) over time to assess continued responsiveness to the drug or steroid.
1-20. (canceled).
A method for determining steroid responsiveness in a subject, the method comprising the steps of:
A method for determining steroid responsiveness in a subject undergoing steroid treatment, comprising:
A method for determining steroid responsiveness in a sample, comprising:
A method for determining an effective dose of a steroid in a subject, the method comprising the steps of:
A method for monitoring a subject's ability to respond to a steroid, the method comprising the steps of:
A method for determining drug responsiveness in a subject undergoing drug treatment, the method comprising the steps of:
A method for determining drug responsiveness in a sample, comprising:
A method for determining responsiveness of a cell to a body fluid, the method comprising the steps of:
A kit for determining steroid responsiveness in a subject comprising:
Dependencies are inferred from the claim text.